U.S. markets closed
  • S&P 500

    4,223.70
    -22.89 (-0.54%)
     
  • Dow 30

    34,033.67
    -265.66 (-0.77%)
     
  • Nasdaq

    14,039.68
    -33.17 (-0.24%)
     
  • Russell 2000

    2,314.69
    -5.38 (-0.23%)
     
  • Crude Oil

    71.67
    -0.48 (-0.67%)
     
  • Gold

    1,813.60
    -47.80 (-2.57%)
     
  • Silver

    27.03
    -0.78 (-2.81%)
     
  • EUR/USD

    1.1998
    -0.0135 (-1.12%)
     
  • 10-Yr Bond

    1.5690
    +0.0700 (+4.67%)
     
  • GBP/USD

    1.3989
    -0.0094 (-0.67%)
     
  • USD/JPY

    110.6710
    +0.6370 (+0.58%)
     
  • BTC-USD

    38,843.48
    -1,219.56 (-3.04%)
     
  • CMC Crypto 200

    961.10
    -31.37 (-3.16%)
     
  • FTSE 100

    7,184.95
    +12.47 (+0.17%)
     
  • Nikkei 225

    29,291.01
    -150.29 (-0.51%)
     

Global Influenza Markets, Epidemiology and Patient Flow Analysis Report 2020-2035 - Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries - ResearchAndMarkets.com

·2 min read

The "Global Influenza Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Influenza Epidemiology and Patient Flow Analysis - 2021, provides Influenza epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Influenza patients, history of the disease at the population level (Influenza prevalence, Influenza incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Influenza patient flow: Influenza prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Influenza patients by age group, gender

  • Forecast: Influenza epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Influenza market sizing, assessing market potential, and developing drug forecast models

  • Identify Influenza patients segments through age groups, gender, and disease sub-types

  • Develop Influenza population-based health management frameworks

  • Evaluate Influenza market opportunities, identify target patient population

  • Align marketing decisions with the Influenza target population

  • Communicate leadership and health authorities about your Influenza target patient population

Key Topics Covered:

1. Research Methodology

2. Influenza Patients Definition

3. US Influenza Epidemiology and Patient Flow

4. Germany Influenza Epidemiology and Patient Flow

5. France Influenza Epidemiology and Patient Flow

6. Italy Influenza Epidemiology and Patient Flow

7. Spain Influenza Epidemiology and Patient Flow

8. UK Influenza Epidemiology and Patient Flow

9. Europe Influenza Epidemiology and Patient Flow

10. Japan Influenza Epidemiology and Patient Flow

11. Global Influenza Epidemiology and Patient Flow

For more information about this report visit https://www.researchandmarkets.com/r/86vtjp

View source version on businesswire.com: https://www.businesswire.com/news/home/20210514005182/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900